FZR1 and Miyoshi myopathy: Analysis of data from GSE6691 (Figure 1B) demonstrated increased expression in newly diagnosed MM patients (n=12; p = 0.01), while analysis of data from GSE6647 (Figure 1C) demonstrated a significant increase in FZR1 expression across 4 different stages of plasma cell dyscrasias - monoclonal gammopathy of undetermined significance (MGUS; n=22; p = 0.009), smoldering MM (n=24; p = 0.004), newly diagnosed MM (n=72; p = 0.02) and relapsed MM (n=27; p = 0.02).